Investors in these stocks should be very aware that early-stage biotech stocks have huge upside but also bust potential, and to invest within your risk tolerance accordingly. Billy Duberstein and ...

1.1a Congress must establish a National Biotechnology Coordination Office (NBCO) within the Executive Office of the President with a director, appointed by the President, who would coordinate ...

Lining the hallowed passage—the path on which every prospect who is at the draft will walk before their name is called—will be handcrafted wooden logos for all 32 teams, meticulously created ...

Young is one of more than 1,000 dog owners participating in a first-of-its-kind clinical trial at more than 70 facilities around the country and spearheaded by Bay Area biotech company Loyal.

His ousting of Peter Marks—a senior official at the Food and Drug Administration and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns that the ...

President Trump vowed Monday to fight for a Long Island town to keep its school’s team name and logo after New York state demanded their removal because of a ban on Native American imagery.

“I agree with the people in Massapequa, Long Island, who are fighting furiously to keep the Massapequa Chiefs logo on their Teams and School,” Trump posted on Truth Social on Monday.

The logos of Big Tech companies and key associations were featured prominently Monday at the White House Easter Egg Roll, offering an unprecedented scene and use of the grounds to promote private ...

Investing.com -- Biotech stocks climbed Monday after new FDA Commissioner Dr. Marty Makary laid out a clear and collaborative regulatory strategy that analysts say bodes well for drug developers.

Shanghai-based VelaVigo has been busy. The biotech granted Avenzo Therapeutics ex-China rights to a Nectin4xTROP2 bispecific antibody-drug conjugate in November, netting up to $50 million in ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

Lorenzo Paoletti, managing director, Biotech Investment Banking at Truist Securities, discussed the effects of recent job cuts and restructuring of the regulatory agencies with GEN Edge.